Why is EVFM stock so low?

However, Evofem took a blow when it had to abandon a clinical trial in October that failed to reflect complete results for the prevention of chlamydia and gonorrhea. Pelletier said the COVID-19 pandemic stifled participation in the clinical trial. That sent Evofem's stock falling.

What is the future of Evofem stock?

The average one-year price target for Evofem Biosciences, Inc. is $229.5. The forecasts range from a low of $227.25 to a high of $236.25.

What is the price prediction for EVFM?

Given the current short-term trend, the stock is expected to fall -44.93% during the next 3 months and, with a 90% probability hold a price between $0.0024 and $0.0109 at the end of this 3-month period.

What happened to Evofem Biosciences Inc.?

In December 2023, Evofem, a commercial stage women's health innovator, entered into a definitive agreement to be acquired by Aditxt, Inc. (Nasdaq: ADTX), which Evofem believes is a compelling opportunity to accelerate its growth trajectory, as a subsidiary of Aditxt, into a multi-product women's health franchise.

Will EVFM be delisted?

In 2022, Evofem was delisted from the NASDAQ exchange and watched as its healthcare investors drifted away.

Is Evofem a good buy?

The consensus rating for Evofem Biosciences is Hold while the average consensus rating for medical companies is Moderate Buy.

Did EVFM stock split?

Evofem Biosciences stock (symbol: EVFM) underwent a total of 3 stock splits. The most recent stock split occured on May 18th, 2023.

How many outstanding shares does Evofem have?

According to Evofem Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 4,236,477. At the end of 2023 the company had 4,236,477 shares outstanding.

What is the stock target price?

A target price is an estimate of the future price of a stock. Target prices are based on earnings forecasts and assumed valuation multiples. Target prices can be used to evaluate stocks and may be even more useful than an equity analyst's rating.

How do I buy EVFM stock?

How to buy EVFM stock on Public Sign up for a brokerage account on Public. It's easy to get started. Add funds to your Public account. ... Choose how much you'd like to invest in EVFM stock. ... Manage your investments in one place.

What is the target price for IDEX stock?

The average price target for IDEX Corporation is $253.33. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $285.00 ,the lowest forecast is $210.00.

Xeris Pharmaceuticals's analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.

US-based biotech Aditxt is venturing into the women's health market after it acquired Evofem Biosciences in a deal worth approximately $100m.

Who is the CEO of Evofem?

Saundra Pelletier - Evofem Biosciences, Inc.

Who are the shareholders of EVFM?

Top Shareholders Holder # of Shares Type Daniel Janney 2,667,024 Insider Maxim Gorbachev 1,585,549 Insider Rmi Investments S.A.R.L. 1,585,549 Insider George Mahaffey 171,040 Insider 4 more rows

Evfm Message Board (2024)

1. Evofem Biosciences, Inc. (EVFM) Stock Forum & Discussion

Find the latest Evofem Biosciences, Inc. (EVFM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and ...
Find the latest Evofem Biosciences, Inc. (EVFM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Holder	# of Shares	Type
Daniel Janney	2,667,024	Insider
Maxim Gorbachev	1,585,549	Insider
Rmi Investments S.A.R.L.	1,585,549	Insider
George Mahaffey	171,040	Insider

Evfm Message Board (2024)

FAQs